Agile Therapeutics, Inc.
Historical 13F Holders
Symbol
AGRX
CUSIP
00847L308
All holders as of
Q1 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2024 Q1
1
1.75 k
$596.00
$0
2023 Q4
23
262 k
$511 k
$0
2023 Q3
18
148 k
$355 k
$0
2023 Q2
17
144 k
$426 k
$0